TOWN, N.J.--(BUSINESS WIRE)-- Flexible Stenting Solutions, Inc. (“FSS”), a leading developer of next generation peripheral arterial, venous, neurovascular and biliary stents, announced today that it has received 510(k) clearance for additional sizes – including 9 and 10 mm diameters in lengths up to 100 mm – of the FlexStent® Biliary Self-Expanding Stent System.
The FlexStent® Biliary Self-Expanding Stent System is indicated for the palliative treatment of biliary strictures resulting from malignant neoplasms. Expansion of the FlexStent® Biliary Stent size range provides the physician with additional options in the treatment of these strictures. FSS’s nearly fully connected stent has always allowed for a straight forward, simple and accurate delivery. As always, the delivery system is easy to use assuring stent placement accuracy with low deployment forces.
“We are committed to providing our novel, next generation self-expanding stents in many sizes and for numerous indications.” Janet Burpee, FSS’s CEO, commented. “This 510(k) clearance for the 9 and 10 mm diameters of the biliary stent furthers our commitment to providing physicians with a straight forward stenting solution.”
About Flexible Stenting Solutions Inc.
Flexible Stenting Solutions Inc. (FSS) is a leading developer of third-generation flexible peripheral arterial, venous, neurovascular and biliary stents. Its fully connected stent has coupled technology with clinical needs by providing an atraumatic, highly durable and fatigue resistant stent with superior radial stiffness, flexibility and conformability. FSS is an ISO 13485:2003 certified company.
For further information on Flexible Stenting Solutions, please visit the company website at www.flexiblestent.com.
FlexStent® is a registered trademark of Flexible Stenting Solutions, Inc.
© 2012 Flexible Stenting Solutions, Inc.
Flexible Stenting Solutions, Inc.
Janet Burpee, 732-578-0060